Related Experiment Video
Updated: Aug 7, 2026
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Preclinical and Coclinical Studies in Prostate Cancer
Ming Chen1, Pier Paolo Pandolfi1
1Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215.
Cold Spring Harbor Perspectives in Medicine
|October 18, 2017
Summary
A new co-clinical trial platform aims to speed up drug testing for metastatic castration-resistant prostate cancer (mCRPC). This approach aligns preclinical and clinical studies to personalize late-stage prostate cancer therapies.
Area of Science:
- Oncology
- Translational Medicine
Background:
- Metastatic castration-resistant prostate cancer (mCRPC) remains a fatal disease with a critical need for improved preclinical drug testing.
- Current preclinical models struggle to efficiently translate genomic insights into patient-specific therapies for advanced prostate cancer (PCa).
Purpose of the Study:
- To introduce and advocate for a novel "co-clinical trial project" platform to accelerate drug development for mCRPC.
- To enhance the efficiency of preclinical studies and optimize clinical trial and experimental drug testing for late-stage prostate cancer.
Main Methods:
- The proposed platform closely aligns in vivo preclinical studies with early clinical trials.
- It utilizes genetically engineered mouse models (GEMMs) in defined genetic contexts for in vivo drug testing.
- This facilitates personalized therapy development based on individual patient molecular profiles.
Main Results:
- The co-clinical trial project paradigm is detailed, outlining its principles and essential components.
- Representative success stories demonstrating the platform's efficacy are presented.
- Future therapeutic strategies for mCRPC are discussed in the context of this translational approach.
Conclusions:
- The co-clinical trial project offers a paradigm shift to expedite drug discovery and development for mCRPC.
- This integrated approach holds promise for personalizing therapies and improving outcomes for patients with advanced prostate cancer.
- Further exploration of this model is crucial for advancing treatment options for mCRPC.
Related Concept Videos
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...